Abstract:Backgroud High comorbidity rates have been reported in patients with atherosclerosis and osteoporosis, posing a serious risk to the health and well-being of elderly patients. To improve and update clinical practice regarding the joint treatment of these two diseases, the common mechanisms of atherosclerosis and osteoporosis need to be clarified. MicroRNAs (miRNAs), are importance molecules in the pathogenesis of human diseases, including in cardiovascular and orthopedic fields. They have garnered interest as potential targets for novel therapeutic strategies. However, the key miRNAs involved in atherosclerosis and osteoporosis and their precise regulation mechanisms remain unknown. Paeonol (Pae), an active ingredient in Cortex Moutan, has shown promising results in improving both lipid and bone metabolic abnormalities. However, it is uncertain whether this agent can exert a cotherapeutic effect on atherosclerosis and osteoporosis. Objective This study aimed to screen important shared miRNAs in atherosclerotic and osteoporotic complications, and explore the mechanism of the protective effects of Pae against atherosclerosis and osteoporosis in high-fat diet (HFD)-fed ApoE −/− mice. Methods An experimental atherosclerosis and osteoporosis model was established in 40-week-old HFD ApoE −/- mice. Various techniques such as Oil Red O staining, HE staining and micro-CT were used to confirm the co-occurrence of these two diseases and efficacy of Pae in addition to the associated biochemical changes. Bioinformatics was used to screen key miRNAs in the atherosclerosis and osteoporosis model, and gene involvement was assessed through serum analyses, qRT-PCR, and western blot. To investigate the effect of Pae on the modulation of the miR let-7g/HMGA2/CEBPβ pathway, Raw 264.7 cells were cocultured with bone marrow mesenchymal stem cells (BMSCs) and treated with an miR let-7g mimic/inhibitor. Results miR let-7g identified using bioinformatics was assessed to evaluate its participation in atherosclerosis-osteoporosis. Experimental analysis showed reduced miR let-7g levels in the atherosclerosis-osteoporosis mice model. Moreover, miR let-7g was required for BMSC - Raw 264.7 cell crosstalk, thereby promoting foam cell formation and adipocyte differentiation. Treatment with Pae significantly reduced plaque accumulation and foam cell number in the aorta while increasing bone density and improving trabecular bone microarchitecture in HFD ApoE −/- mice. Pae also increased the level of miR let-7g in the bloodstream of model mice. In vitro studies, Pae enhanced miR let-7g expression in BMSCs, thereby suppressing the HMGA2/CEBPβ pathway to prevent the formation of foam cells and differentiation of adipocytes induced by oxidized low-density lipoprotein (ox-LDL). Conclusion The study results suggested that miR let-7g participates in atherosclerosis -osteoporosis regulation and that Pae acts as a potential therapeutic agent for preventing atherosclerosis-osteoporosis through regulatory effects on the miR let-7g/HMGA2/CEBPβ pathway to hinder foam cell formation and adipocyte differentiation.

Puerarin Promotes the Viability and Differentiation of MC3T3-E1 Cells by Enhancing LC3B-mediated Autophagy Through Downregulation of Mir-204

Puerarin Promotes the Viability and Differentiation of MC3T3-E1 Cells by Mir-204-regulated Runx2 Upregulation

Puerarin Inhibits TRPM3/miR-204 to Promote MC3T3-E1 Cells Proliferation, Differentiation and Mineralization

Puerarin Reduces Endothelial Progenitor Cells Senescence Through Augmentation of Telomerase Activity

CHNQD-00603 Promotes Osteogenic Differentiation of Bone Marrow Mesenchymal Stem Cells by the miR-452-3p-Mediated Autophagy Pathway

Effect of Puerarin on Osteogenic Differentiation in vitro and on New Bone Formation in vivo

Puerarin Stimulates Osteoblasts Differentiation and Bone Formation Through Estrogen Receptor, P38 MAPK, and Wnt/β-catenin Pathways.

The Study of Anti-Metabolic Syndrome Effect of Puerarin in Vitro

Puerarin Promotes the Osteogenic Differentiation of Rat Dental Follicle Cells by Promoting the Activation of the Nitric Oxide Pathway.

Puerarin Suppresses the Self-Renewal of Murine Embryonic Stem Cells by Inhibition of REST-MiR-21 Regulatory Pathway

Puerarin leads to K562 cell apoptosis of chronic myelogenous leukemia via induction of autophagy

Puerarin promotes the proliferation of osteoblasts in older female patients with osteoporosis

Icariin Regulates the Osteoblast Differentiation and Cell Proliferation of MC3T3-E1 Cells Through Microrna-153 by Targeting Runt-related Transcription Factor 2

The Proliferation, Differentiation, and Mineralization Effects of Puerarin on Osteoblasts in Vitro

Stimulatory Effect of Puerarin on Bone Formation through Activation of PI3K/Akt Pathway in Rat Calvaria Osteoblasts

Resveratrol induces proliferation and differentiation of mouse pre-osteoblast MC3T3-E1 by promoting autophagy

MicroRNA let-7g links foam cell formation and adipogenic differentiation: a key regulator of Paeonol treating atherosclerosis-osteoporosis

The Effect of Quercetin on the Osteogenesic Differentiation and Angiogenic Factor Expression of Bone Marrow-Derived Mesenchymal Stem Cells

Protective Effect of Photobiomodulation against Hydrogen Peroxide-Induced Oxidative Damage by Promoting Autophagy through Inhibition of PI3K/AKT/mTOR Pathway in MC3T3-E1 Cells

Mir-532-3p Inhibits Osteogenic Differentiation in MC3T3-E1 Cells by Downregulating ETS1.

The effective constituent puerarin, from Pueraria lobata, inhibits the proliferation and inflammation of vascular smooth muscle in atherosclerosis through the miR-29b-3p/IGF1 pathway